- Home
- PCRX vs TWO Comparison
PCRX vs TWO Comparison
Compare PCRX & TWO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCRX
- TWO
- Stock Information
- Founded
- PCRX 2006
- TWO 2009
- Country
- PCRX United States
- TWO United States
- Employees
- PCRX N/A
- TWO N/A
- Industry
- PCRX Biotechnology: Pharmaceutical Preparations
- TWO Real Estate Investment Trusts
- Sector
- PCRX Health Care
- TWO Real Estate
- Exchange
- PCRX Nasdaq
- TWO Nasdaq
- Market Cap
- PCRX 1.2B
- TWO 1.1B
- IPO Year
- PCRX 2011
- TWO 2009
- Fundamental
- Price
- PCRX $26.67
- TWO $10.01
- Analyst Decision
- PCRX Buy
- TWO Buy
- Analyst Count
- PCRX 6
- TWO 8
- Target Price
- PCRX $30.00
- TWO $12.64
- AVG Volume (30 Days)
- PCRX 766.6K
- TWO 1.9M
- Earning Date
- PCRX 08-05-2025
- TWO 10-27-2025
- Dividend Yield
- PCRX N/A
- TWO 15.59%
- EPS Growth
- PCRX N/A
- TWO N/A
- EPS
- PCRX N/A
- TWO N/A
- Revenue
- PCRX $705,848,000.00
- TWO $257,735,000.00
- Revenue This Year
- PCRX $7.36
- TWO N/A
- Revenue Next Year
- PCRX $10.07
- TWO N/A
- P/E Ratio
- PCRX N/A
- TWO N/A
- Revenue Growth
- PCRX 2.25
- TWO N/A
- 52 Week Low
- PCRX $12.61
- TWO $9.50
- 52 Week High
- PCRX $27.64
- TWO $14.28
- Technical
- Relative Strength Index (RSI)
- PCRX 67.86
- TWO 49.97
- Support Level
- PCRX $25.14
- TWO $9.77
- Resistance Level
- PCRX $27.04
- TWO $9.95
- Average True Range (ATR)
- PCRX 0.78
- TWO 0.17
- MACD
- PCRX 0.18
- TWO 0.02
- Stochastic Oscillator
- PCRX 88.79
- TWO 66.88
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
About TWO Two Harbors Investment Corp
Two Harbors Investment Corp is a real estate investment trust focused on investing in, financing, and managing residential mortgage-backed securities, or RMBS; residential mortgage loans; mortgage servicing rights; and commercial real estate. The majority of the company's investment portfolio is split between agency RMBS purchased from government-sponsored enterprises and nonagency RMBS. Two Harbors derives nearly all of its revenue in the form of interest income collected from its investments. The majority of this income is generated by available-for-sale securities, while residential mortgage loans held for investment in securitization trusts also contribute a sizable amount.